Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Novartis took home the top spot in the 21st Kellogg School Super Bowl Advertising Review with its "Your Attention, Please" ad putting a spotlight on breast health and encouraging cancer screening – ...

Learning Executive, CLO; 20 years enabling companies, teams and individuals attain their maximum potential | Google, Novartis, Microsoft, Accenture, Oracle | Harvard ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

A new barrage of new, glitzy, celebrity-filled ads debuted during Super Bowl 59 on Sunday. Fox, which airs the game, said in ...

Alphabet (GOOGL) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.

Job Title Sort ascending Business Location Site Date Posted Therapeutic Area Partner Regular (Sales), Full time Innovative Medicines Utd.Arab Emir. Dubai Feb 03, 2025 Senior Specialist, IT Information ...

WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' blockbuster heart-failure drug Entresto late on Wednesday.